Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
Stelara’s patents are expiring in September 2023, while a handful of biosimilar drugs are in late-stage development or seeking FDA approval. The FDA approved the drug over a decade ago in September 2009. billion the drug generated in 2021. Johnson & Johnson’s total global earnings from Stelara were $9.72
Let's personalize your content